Zomedica Corp (ZOM)
0.1203
0.00 (0.00%)
USD |
NYAM |
Nov 05, 11:37
Zomedica Net Income (Quarterly): -23.93M for June 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -23.93M |
| March 31, 2024 | -9.16M |
| December 31, 2023 | -22.41M |
| September 30, 2023 | -0.491M |
| June 30, 2023 | -5.249M |
| March 31, 2023 | -6.385M |
| December 31, 2022 | -2.809M |
| September 30, 2022 | -4.995M |
| June 30, 2022 | -5.273M |
| March 31, 2022 | -3.937M |
| December 31, 2021 | -3.291M |
| September 30, 2021 | -6.346M |
| June 30, 2021 | -4.711M |
| March 31, 2021 | -4.037M |
| December 31, 2020 | -4.173M |
| September 30, 2020 | -4.98M |
| June 30, 2020 | -5.308M |
| March 31, 2020 | -2.451M |
| December 31, 2019 | -2.857M |
| September 30, 2019 | -2.846M |
| June 30, 2019 | -2.404M |
| March 31, 2019 | -11.68M |
| December 31, 2018 | -8.422M |
| Date | Value |
|---|---|
| September 30, 2018 | -1.910M |
| June 30, 2018 | -4.144M |
| March 31, 2018 | -2.171M |
| December 31, 2017 | -2.563M |
| September 30, 2017 | -2.081M |
| June 30, 2017 | -1.588M |
| March 31, 2017 | -1.833M |
| December 31, 2016 | -2.702M |
| September 30, 2016 | -1.042M |
| June 30, 2016 | -1.065M |
| February 29, 2016 | -0.0156M |
| November 30, 2015 | -0.0239M |
| August 31, 2015 | -0.0048M |
| May 31, 2015 | -0.0111M |
| February 28, 2015 | -0.0156M |
| November 30, 2014 | -0.0088M |
| August 31, 2014 | -0.0111M |
| May 31, 2014 | -0.0079M |
| February 28, 2014 | -0.0024M |
| November 30, 2013 | -0.0542M |
| August 31, 2013 | -0.0069M |
| May 31, 2013 | -0.0145M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-23.93M
Minimum
Jun 2024
-0.491M
Maximum
Sep 2023
-6.463M
Average
-4.98M
Median
Sep 2020
Net Income (Quarterly) Benchmarks
| Standard BioTools Inc | -26.94M |
| Ainos Inc | -3.195M |
| LENSAR Inc | -9.043M |
| Intelligent Bio Solutions Inc | -2.784M |
| Adagio Medical Holdings Inc | -0.2458M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 6.131M |
| Total Expenses (Quarterly) | 15.17M |
| EPS Diluted (Quarterly) | -0.024 |
| Enterprise Value | 40.25M |
| Gross Profit Margin (Quarterly) | 71.15% |
| Profit Margin (Quarterly) | -390.3% |
| Earnings Yield | -47.38% |
| Normalized Earnings Yield | -25.90 |